Lin SM - Search Results

1

Severe clinical rebound upon withdrawal of corticosteroid before interferon therapy: incidence and risk factors.

Sheen IS, Liaw YF, Lin SM, Chu CM. Sheen IS, et al. Among authors: lin sm. J Gastroenterol Hepatol. 1996 Feb;11(2):143-7. doi: 10.1111/j.1440-1746.1996.tb00051.x. J Gastroenterol Hepatol. 1996. PMID: 8672759

2

Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B.

Lin SM, Tai DI, Chien RN, Sheen IS, Chu CM, Liaw YF. Lin SM, et al. J Viral Hepat. 2004 Jul;11(4):349-57. doi: 10.1111/j.1365-2893.2004.00512.x. J Viral Hepat. 2004. PMID: 15230858 Clinical Trial.

3

Treatment of chronic type B hepatitis in Southeast Asia.

Liaw YF, Lin SM, Sheen IS, Chen TJ, Chu CM. Liaw YF, et al. Among authors: lin sm. Am J Med. 1988 Aug 29;85(2A):147-9. Am J Med. 1988. PMID: 3044079 Clinical Trial.

4

Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial.

Liaw YF, Lin SM, Chen TJ, Chien RN, Sheen IS, Chu CM. Liaw YF, et al. Among authors: lin sm. J Hepatol. 1994 Feb;20(2):175-80. doi: 10.1016/s0168-8278(05)80055-8. J Hepatol. 1994. PMID: 8006397 Clinical Trial.

5

Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B (C) hepatitis.

Liaw YF, Sheen IS, Lin SM, Chen TJ, Chu CM. Liaw YF, et al. Among authors: lin sm. Liver. 1993 Feb;13(1):46-50. doi: 10.1111/j.1600-0676.1993.tb00604.x. Liver. 1993. PMID: 8455424 Clinical Trial.

6

Response of patients with dual hepatitis B virus and C virus infection to interferon therapy.

Liaw YF, Chien RN, Lin SM, Yeh CT, Tsai SL, Sheen IS, Chu CM. Liaw YF, et al. Among authors: lin sm. J Interferon Cytokine Res. 1997 Aug;17(8):449-52. doi: 10.1089/jir.1997.17.449. J Interferon Cytokine Res. 1997. PMID: 9282824

7

Non-surgical treatment of hepatocellular carcinoma.

Lin DY, Lin SM, Liaw YF. Lin DY, et al. Among authors: lin sm. J Gastroenterol Hepatol. 1997 Oct;12(9-10):S319-28. doi: 10.1111/j.1440-1746.1997.tb00516.x. J Gastroenterol Hepatol. 1997. PMID: 9407353 Review.

8

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.

Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF. Lin SM, et al. Hepatology. 1999 Mar;29(3):971-5. doi: 10.1002/hep.510290312. Hepatology. 1999. PMID: 10051505 Clinical Trial.

9

Hepatocyte expression of HBcAg and serum HBeAg in hepatitis B: comparison of polyclonal and monoclonal antibodies during a trial of interferon.

Chu CM, Lin SM, Liaw YF. Chu CM, et al. Among authors: lin sm. J Clin Pathol. 1991 Jan;44(1):21-4. doi: 10.1136/jcp.44.1.21. J Clin Pathol. 1991. PMID: 1705260 Free PMC article. Clinical Trial.

10

Prednisolone withdrawal followed by recombinant alfa-interferon in chronic non-A, non-B hepatitis: interim results of a randomized controlled trial.

Liaw YF, Sheen IS, Lin SM, Chen TJ. Liaw YF, et al. Among authors: lin sm. Gastroenterol Jpn. 1991 Jul;26 Suppl 3:247-50. doi: 10.1007/BF02779311. Gastroenterol Jpn. 1991. PMID: 1909274 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

972 results

Search Page

Filters